Simplex Trading’s PMV Pharmaceuticals PMVP Stock Holding History

Simplex Trading’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$68.3K	Buy	51,000 +50,400	+8,400%	+$64.7K	﹤0.01%	5978
2026 Q1	$744	Buy	+600	New	+$763	﹤0.01%	8663
2025 Q1	–	Sell	-700	Closed	-$1K	–	9393
2024 Q4	$1K	Hold	700	–	–	﹤0.01%	8289
2024 Q3	$1K	Hold	700	–	–	﹤0.01%	8248
2024 Q2	$1K	Sell	700 -100	-13%	-$180	﹤0.01%	8528
2024 Q1	$1K	Sell	800 -8,500	-91%	-$15.9K	﹤0.01%	8621
2023 Q4	$28K	Sell	9,300 -300	-3%	-$794	﹤0.01%	6635
2023 Q3	$58K	Buy	+9,600	New	+$66K	﹤0.01%	5666
2022 Q4	–	Sell	-700	Closed	-$8K	–	10142
2022 Q3	$8K	Sell	700 -9,200	-93%	-$133K	﹤0.01%	8426
2022 Q2	$141K	Buy	9,900 +1,600	+19%	+$23.3K	﹤0.01%	5084
2022 Q1	$172K	Buy	8,300 +8,200	+8,200%	+$145K	﹤0.01%	5371
2021 Q4	$2K	Buy	+100	New	+$2.42K	﹤0.01%	10031

Other funds holding PMVP

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Simplex Trading's PMVP Position: Q2 2026 in Review

Simplex Trading sold out of PMV Pharmaceuticals (PMVP) in Q2 2026, closing a stake of 8,181 shares — an estimated $10.5K sold.

Simplex Trading first reported a position in PMVP in Q4 2021 and held it in 14 quarters. The position peaked at $694K in Q2 2022. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

Simplex Trading reported no remaining PMV Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Simplex Trading sold 8,181 PMV Pharmaceuticals shares in Q2 2026, an estimated $10.5K.
Simplex Trading first reported a position in PMV Pharmaceuticals in Q4 2021 and held it in 14 quarters.
Simplex Trading's PMV Pharmaceuticals position peaked at $694K in Q2 2022.
64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.